3-(2-methyl-1H-indol-3-yl)propan-1-amine hydrochloride
: Prepared according to the general procedure using phenyl hydrazine (1.8 mL, 18 mmol), EtOH (60 mL), and 6-chloro-2hexanone (2 mL, 15 mmol) at 80 °C for 24.5 h. Purified by trituration from CH 2 Cl 2 /Et 2 O to afford SI-2 (1.42 g, 42%) of a pale-yellow shiny solid.
Analytical data for SI-2: 1 H NMR (500 MHz, DMSO-d 6 ) δ 10.80 (s, 1H), 8.09 (br s, 3H), 7.43 (d, J = 7.7 Hz, 1H), 7.23 (d, J = 7.9 Hz, 1H), 6.96 (t, J = 7.0 Hz, 1H), 6.91 (td, J = 7.5, 1.1 Hz, 1H), 2.82 -2.72 (m, 2H), 2.69 (t, J = 7.5 Hz, 2H), 2.32 (s, 3H), 1.84 (p, J = 7.6 Hz, 2H); 13 C NMR (125 MHz, DMSO) δ 135.2, 131.6, 128.0, 119.9, 118.0, 117.3, 110.3, 108.8, 38.6, 28.3, 20.6, 11.2; HRMS (ESI) calcd for (C 12 H 16 N 2 )H + [M+H] + : 189.1386, found: 189.1377 . : Prepared according to a procedure by Feng and coworkers. 3 To a 250-mL RBF was added tryptamine (4.81 g, 30 mmol), phthalic anhydride (4.58 g, 30.9 mmol) , and toluene (176 mL). The RBF was fitted with a reflux condenser and brought to reflux. After 13 h, the reaction mixture was cooled and concentrated in vacuo. Purified by trituration from CH 2 Cl 2 /Hexanes to afford SI-3 (7.77 g, 89%) as a lightyellow solid.
Preparation of 2-Aryl Tryptamines

2-(2-(1H-indol-3-yl)ethyl)isoindoline-1,3-dione
2-(2-(2-bromo-1H-indol-3-yl)ethyl)isoindoline-1,3-dione : Prepared according to a procedure by Feng and coworkers. 3 To a 100-mL RBF was added SI-3 (1.76 g, 6.07 mmol) and CHCl 3 /THF (1:1, 0.1 M). The mixture was cooled to -10 °C in a bath. Pyridinium tribromide (2.04 g, 6.37 mmol) was added portionwise over the course of 1 min. The reaction progress was monitored by TLC. After 1 h, the reaction was quenched with sat. aq. Na 2 S 2 O 3 . The mixture was stirred for 30 min, then extracted three times with CH 2 Cl 2 and dried over anh. MgSO 4 . Purified by trituration from CH 2 Cl 2 and Hexanes to afford SI-4 (1.93 g, 86%) as a sand-colored solid. : Prepared according to a procedure by Chu and coworkers. 5 To a 100-mL flask was added bromoindole SI-4 (877 mg, 2.38 mmol), phenylboronic acid (363 mg, 2.98 mmol), PhMe/EtOH (1:1, 60 mL), 1.0 M aq. Na 2 CO 3 ·H 2 O (6 mL), and LiCl (303 mg, 7.14 mmol). The mixture was sparged with N 2 for 25 min, then Pd(PPh 3 ) 4 (138 mg, 119 µmol) was added and the mixture was brought to reflux. After 2.5 h, the reaction mixture was cooled to ambient temperature, then filtered through anh. Na 2 SO 4 and concentrated. Purified by flash column chromatography (1530% EtOAc/Hexanes) to afford SI-5 (572 mg, 66%) as a yellow solid.
2-(2-(2-phenyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione
Analytical data match those reported in the literature. 6 4 Gerasyuto, Aleksey I.; Hsung, Richard P.; Sydorenko, Nadiya; Zificsak, Craig A. Org. Biomol. Chem. 2005 , 3, 2140 -2144 Fisher, M. H.; Goulet, M. T.; Wyratt, M. J. Tetrahedron Lett. 1997, 38, 3871-3874. 6 Kolundzic, F.; Noshi, M. N.; Tjandra, M.; Movassaghi, M.; Miller, S. J. J. Am. Chem. Soc. 2011, 133, 9104-9111. : To a 100-mL RBF was added SI-5 (572 g, 1.56 mmol), CH 2 Cl 2 /MeOH (1:1, 31 mL), and 50-60% hydrazine hydrate (1.5 mL). After heating to reflux for 13.5 h, the milky-white heterogeneous reaction mixture was cooled to ambient temperature, vacuum-filtered and the filtrate was concentrated in vacuo. Purified by flash column chromatography (1050% MeOH/CH 2 Cl 2 ) to afford SI-6 (371 mg, quant.) as a tan residue.
2-(2-phenyl-1H-indol-3-yl)ethanamine
Analytical data match those reported in the literature. 7
Step 1 [2-(2-(2-(3,4-dimethoxyphenyl)-1H-indol-3-yl)ethyl)isoindoline-1,3-dione (SI-7)]: Prepared according to a procedure by Chu and coworkers. 8 To a 100-mL flask was added bromoindole SI-4 (675 mg, 1.83 mmol), 3,4-dimethoxyphenylboronic acid (417 mg, 2.29 mmol), PhMe/EtOH (1:1, 46 mL), 1.0 M aq. Na 2 CO 3 ·H 2 O (4.6 mL), and LiCl (233 mg, 5.49 mmol). The mixture was sparged with N 2 for 30 min, then Pd(PPh 3 ) 4 (106 mg, 91.5 µmol) was added. The mixture was purged for an additional 15 min, then brought to reflux. After 6 h, the reaction mixture was cooled to ambient temperature. The reaction mixture was diluted with EtOAc, and the aqueous layer was removed. The organic layer was washed three times with 1.0 M NaOH, once with brine, and dried over anh. MgSO 4 . The residue was used without further purification.
Step 2 [2-(2-(3,4-dimethoxyphenyl)-1H-indol-3-yl)ethanamine (SI-8)]: To the above residue of SI-7 was added CH 2 Cl 2 /MeOH (1:1, 37 mL), and 50-60% hydrazine hydrate (1.7 mL). After heating to reflux for 16 h, the reaction mixture was cooled to ambient temperature and the brown heterogeneous mixture was vacuum filtered using a fritted funnel. The filtrate was concentrated, then diluted with 1.0 M NaOH. The mixture was extracted four times with 4:1 CHCl 3 /i-PrOH and dried over anh. Na 2 SO 4 . The residue was used without further purification. 7 Preciado, S.; Mendive-Tapia, L.; Albericio, F.; Lavilla, R. J. Org. Chem., 2013, 78, 8129-8135. 8 Chu, L.; Fisher, M. H.; Goulet, M. T.; Wyratt, M. J. Tetrahedron Lett. 1997, 38, 3871-3874. 
Preparation of C3-Alkyl Sulfonamides
To a solution of tryptamine in anh. CH 2 Cl 2 maintained under a positive pressure of nitrogen was added NEt 3 and cooled to 0 °C. To the stirred solution was added tosyl or mesyl in one portion and the reaction was allowed to slowly warm to ambient temperature. The reaction was allowed to stir an additional 12 h. The solution was then diluted with CH 2 Cl 2 , washed with 10% aq. HCl, aq. NaHCO 3 , and brine. The organic layer was passed through a plug of silica, which was washed with CH 2 Cl 2. The combined organic layers were dried over anh. MgSO 4 or anh. Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash column chromatography to give the desired products.
N-(2-(1H-indol-3-yl)ethyl)-4-methylbenzenesulfonamide (3l)
: Prepared according to the general procedure using tryptamine (2.4 g, 15 mmol), CH 2 Cl 2 (24 mL), NEt 3 (2.3 mL, 16.5 mmol), and TsCl (3.43 g, 18 mmol) for 16 h at 023 °C. Purified by flash column chromatography (5% MeOH/CH 2 Cl 2 ) to afford 3l (4.13 g, 88%) as a pale orange solid.
Analytical data match those reported in the literature. 9
N-(2-(1H-indol-3-yl)ethyl)methanesulfonamide (3k)
: Prepared according to the general procedure using tryptamine (801 mg, 5 mmol), CH 2 Cl 2 (8.3 mL), NEt 3 (840 µL, 6 mmol), and MsCl (0.46 mL, 6 mmol) for 12 h at 23 °C. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 3k (0.792 g, 66%) as a brown solid.
Analytical data for 3k: 1 H NMR (500 MHz, CDCl 3 ): δ 8.09 (br s, 1H), 7.59 (d, J = 7.9 Hz, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.26 -7.19 (m, 1H), 7.14 (ddd, J = 8.1, 6.8, 1.0 Hz, 1H), 7.09 (d, J = 2.4 Hz, 1H), 4.26 (t, J = 5.3 Hz, 1H), 3.47 (q, J = 6.4 Hz, 2H), 3.06 (t, J = 6.5 Hz, 2H), 2.83 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ): δ 136. 4, 126.9, 122.7, 122.4, 119.7, 118.5, 111.6, 111.4, 43.2, 40.1, 26. 
4-methyl-N-(2-(2-methyl-1H-indol-3-yl)ethyl)benzenesulfonamide (3a)
: Prepared according to the general procedure using 2-methyltryptamine SI-1 (4.37 g, 25.1 mmol), CH 2 Cl 2 (41.8 mL), NEt 3 (4.24 mL, 30.2 mmol), and TsCl (5.76 g, 30.2 mmol) for 12 h at 23 °C. Purified by flash column chromatography (25% EtOAc/Hexanes) to afford 3a (4.62 g, 53% over two steps) as a white solid.
Analytical data match those reported in the literature. 10
N-(2-(2-methyl-1H-indol-3-yl)ethyl)methanesulfonamide (3d)
: Prepared according to the general procedure using 2-methyltryptamine SI-1 (871 mg, 5 mmol), CH 2 Cl 2 (8.33 mL), NEt 3 (840 µL, 6 mmol), and MsCl (460 µL, 6 mmol) for 12 h at 23 °C. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 3d (548 mg, 43% over two steps) as a yellow oil/amorphous solid.
Analytical data for 3d: 1 H NMR (500 MHz, CDCl 3 ): δ 8.00 (s, 1H), 7.44 (d, J = 7.6 Hz, 1H), 7.19 (d, J = 7.9 Hz, 1H), 7.08 (td, J = 7.5, 1.4 Hz, 1H), 7.04 (ddd, J = 8.0, 7.2, 1.2 Hz, 1H), 4.47 (t, J = 6.3 Hz, 1H), 3.27 (q, J = 6.6 Hz, 2H), 2.89 (t, J = 6.8 Hz, 2H), 2.67 (s, 3H), 2.29 (s, 3H); 13 C NMR (125 MHz, CDCl 3 ): δ 135. 1, 132.6, 128.0, 121.0, 119.2, 117.4, 110.4, 106.9, 43.3, 39.5, 24.9, 11.4 ; HRMS (ESI) calcd for (C 12 H 16 N 2 O 2 S)H + [M+H] + : 253.1005, found: 253.1004. (3b): Prepared according to the general procedure using 2-phenyltryptamine SI-6 (286 mg, 1.21 mmol), CH 2 Cl 2 (2 mL), NEt 3 (354 µL, 2.54 mmol), and TsCl (254 mg, 1.33 mmol) for 14 h at 23 °C. Purified by flash column chromatography (2025% EtOAc/Hexanes) to afford 3b (282 mg, 60% over two steps) as an off-white solid.
4-methyl-N-(2-(2-phenyl-1H-indol-3-yl)ethyl)benzenesulfonamide
Analytical data match those reported in the literature. 11 10 Righi, M.; Topi, F.; Bartolucci, S.l Bedini, A.; Piersanti, G.; Spadoni, G. J. Org. Chem. 2012, 77, 6351-6357. 11 Kieffer, M. E.; Chuang, K. V.; Reisman, S. E. Chem. Sci. 2012, 3, 3170-3174.
N-(2-(2-(3,4-dimethoxyphenyl)-1H-indol-3-yl)ethyl)-4-methylbenzenesulfonamide
(3c): Prepared according to the general procedure using unpurified 2-aryltryptamine SI-8 (1.83 mmol), CH 2 Cl 2 (3 mL), NEt 3 (307 µL, 2.20 mmol), and TsCl (383 mg, 2.01 mmol) for 18 h at 23 °C. Purified by flash column chromatography (03% MeOH/CH 2 Cl 2 ) to afford 3c (267 mg, 32% over three steps) as a tan powder.
Analytical data for 3c: 1 H NMR (500 MHz, DMSO-d 6 ) δ 11.09 (s, 1H), 7.78 (t, J = 5.4 Hz, 1H), 7.67 (d, J = 7.9 Hz, 2H), 7.40 -7.34 (m, 3H), 7.32 (d, J = 8.1 Hz, 1H), 7.12 (s, 1H), 7.10 -7.01 (m, 3H), 6.98 (t, J = 7.5 Hz, 1H), 3.82 (s, 3H), 3.82 (s, 3H), 3.03 -2.88 (m, 4H), 2.36 (s, 3H); 13 C NMR (125 MHz, DMSO) δ 148.8, 148.4, 137.7, 135.7, 134.8, 129.5 (x2), 128.5, 126.5 (x2), 125.2, 121.2, 120.0, 118.7, 117.8, 112.0, 111.4, 111.0, 107.1, 55.6, 55.5, 43.3, 25.4, 20.9 ; HRMS (ESI) calcd for (C 25 (3e): Prepared according to the general procedure using 2-methylhomotryptamine SI-2 (658 mg, 2.93 mmol), CH 2 Cl 2 (4.9 mL), NEt 3 (857 µL, 6.15 mmol), and TsCl (614 mg, 322 mmol) for 17 h at 23 °C. Purified by flash column chromatography (CH 2 Cl 2 ) to afford 3e (853 mg, 85%) as an off-white shiny solid. (3f): Prepared according to the general procedure using homotryptamine SI-2 (211 mg, 0.95 mmol), CH 2 Cl 2 (1.7 mL), NEt 3 (31 µL, 2.2 mmol), and MsCl (100 µL, 1.2 mmol) for 12 h at 23 °C. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 3f (0.153 g, 60%) as a yellow oil.
4-methyl-N-(3-(2-methyl-1H-indol-3-yl)propyl)benzenesulfonamide
N-(3-(2-methyl-1H-indol-3-yl)propyl)methanesulfonamide
Analytical data for 3f: 1 2, 131.2, 128.3, 120.9, 119.1, 117.7, 110.3, 110.1, 43.0, 39.8, 30.4, 21.1, 11.5 
Preparation of C3-Methyl Carbamate
methyl (3-(2-methyl-1H-indol-3-yl)propyl)carbamate (SI-9): Prepared according to a procedure by Fong and Copp. 13 To a mixture of homotryptamine SI-2 (378 mg, 1.68 mmol) in EtOAc (3.4 mL) was added 1.0 M NaOH (2.1 mL) and methyl chloroformate (156 µL, 2.02 mmol). After 19 h at 23 C, the reaction mixture was poured into a separatory funnel. The organic layer was separated, washed once with water, dried over anh. Na 2 SO 4 and concentrated in vacuo. Purified by flash column chromatography (3.75% MeOH/CH 2 Cl 2 ) to afford SI-9 (251 mg, 61%) as a light yellow solid.
Analytical data for SI-9: 1 1, 135.3, 130.9, 128.5, 120.9, 119.1, 117.8, 110.8, 110.2, 52.0, 40.9, 30.6, 21.3, 11.5 
Preparation of Sulfonamide 3h
4-methyl-N-((3-methyl-1H-indol-2-yl)methyl)benzenesulfonamide (3h): Prepared according to a modified procedure by Bandini and coworkers. 14 To a 50-mL RBF was added 3-methyl-1Hindole-2-carbaldehyde (300 mg, 2.07 mmol) and TsNH 2 (532 mg, 3.11 mmol). The RBF was fitted with a reflux condenser greased at the joint, purged with N 2 , and toluene (4.5 mL) and Ti(OEt) 4 (868 µL, 4.14 mmol) was added down the inside walls of the reflux condenser. An additional volume of toluene (4.5 mL) was washed down the inside walls of the reflux condenser. The reaction mixture was stirred at 120 °C for 4 h. After cooling to ambient temperature, the volatiles were concentrated in vacuo. The RBF containing the bright red-orange residue was purged with N 2 , diluted with THF (8.6 mL) and MeOH (8.6 mL), and cooled with an ice/water bath. NaBH 4 (313 mg, 8.28 mmol) was added, and the reaction was warmed to room temperature overnight. After 14.5 h, the reaction mixture was cooled with an ice/water bath and quenched with water. The solvent was removed in vacuo and the resulting residue was diluted with water and extracted three times with CH 2 Cl 2 . The combined organic layers were washed twice with water, back-extracted once with CH 2 Cl 2 , washed once with brine, and dried over anh. Na 2 SO 4 . Purified by flash column chromatography (2030% EtOAc/Hexanes) to afford 3h (383 mg, 59%) as a light orange-yellow solid. 8, 136.5, 135.8, 129.7 (x2), 128.7, 128.5, 127.0 (x2), 122.4, 119.2, 118.7, 110.9, 109.4, 38.4, 21.5, 8 
Preparation of Indole Acetic Acid Derivatives
2-(2-methyl-1H-indol-3-yl)acetic acid (3j) (Step 1): Prepared according to a procedure by Bullock and Fox. 15 Phenyl hydrazine (4.9 mL, 50 mmol), EtOH (36 mL), levulinic acid (5.1 mL, 50 mmol), and 18.0 M H 2 SO 4 (4 mL) were heated to reflux. After 24 h, the mixture was cooled to ambient temperature and the EtOH was concentrated in vacuo. The residue was dissolved in EtOAc, washed once with water, three times with 1.0 M HCl, three times with water, once with brine, and dried over anh. Na 2 SO 4 . Purified by flash column chromatography (2530% EtOAc/Hexanes) to provide a mixture of pyridazinone and indole ethyl acetate, which was used without further purification.
Step 2: The residue from the first step was diluted with water (50 mL), NaOH added (6.0 g, 150 mmol), and the mixture brought to reflux. After 21 h, the reaction mixture was acidified with 1.0 M HCl to pH = 1, then extracted four times with CH 2 Cl 2 . The combined organic layers were washed once with water, once with brine, and dried over anh. Na 2 SO 4 to afford 1.55 g of the indole acetic acid as a reddish-brown solid. The combined aqueous layers were filtered and washed with water and Hexanes to produce an additional 1.19 g of product, affording a combined 2.74 g of 3j (29% over two steps). 
N-benzyl-2-(2-methyl-1H-indol-3-yl)acetamide (3i):
To a 100-mL RBF was added indole acetic acid 3j (1.19 g, 6.29 mmol) and CH 2 Cl 2 (21 mL). NEt 3 (1.9 mL, 13.8 mmol) was added to the mixture, then EDCI (1.45 mg, 7.55 mmol) after five min. The mixture was allowed to stir for 20 min, then benzyl amine (714 µL, 6.92 mmol) was added. After 18 h, the reaction mixture was poured into a separatory funnel and washed with 1.0 M NaOH twice and once with water. The combined aqueous layers were back-extracted once with CH 2 Cl 2 . The combined organic layers were washed with brine and dried over anh. Na 2 SO 4 . Purified by flash column chromatography (5% MeOH/CH 2 Cl 2 ) to afford 3i (1.40 g, 80%) as an orange-yellow solid. 
General Procedure for the Pd-catalyzed Spirocyclization of Indole-based Bis-nucleophiles
Indole substrate (0.20 mmol), Pd 2 (dba) 3 ·CHCl 3 (5 mg, 5.0 µmol, 5 mol % Pd) and Xantphos (6 mg, 11 µmol) were added to an oven-dried 16x100 borosilicate test tube. The test tube was covered with a rubber septum and sealed with Teflon tape or parafilm. The test tube was purged with N 2 , anh. CH 2 Cl 2 (5 mL) was added, and the mixture was maintained under a positive pressure of nitrogen. Exogenous base (0.30 mmol) was added to this mixture if required, and the mixture was either heated or maintained at ambient temperature as indicated. After 15 min, propargyl tert-butyl carbonate 1 (0.26 mmol) was added to the reaction mixture. After consumption of starting material as judged by TLC, the reaction was filtered through a pipet plug of Celite and concentrated in vacuo. The residue was purified by flash column chromatography to give the desired products. (3-(2,3-dimethyl-1H-indol-1-yl) prop-1-en-2-yl)-2,3-dimethyl-3H-indole (2): Prepared according to the general procedure using 2,3-dimethylindole (73 mg, 0.50 mmol), propargyl carbonate 1 (85.9 mg, 0.55 mmol), [Pd(allyl)cod]BF 4 (17 mg, 50 µmol), DPEphos (30 mg, 55 µmol), and toluene (5 mL) at 80 °C for 18 h. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 2 (54 mg, 33%) as a yellow solid. 143.7, 143.3, 136.0, 132.1, 128.5, 128.5, 126.0, 121.8, 120.6, 120.6, 118.8, 117.9, 111.6, 108.2, 106.8, 61.8, 43.1, 20.0, 15.7, 9.4, 8.8 1, 153.9, 143.9, 141.9, 138.3, 137.5, 129.8 (x2), 128.3, 127.4 (x2), 124.8, 123.4, 120.4, 112.6, 55.9, 43.3, 36.4, 29.3, 21.5, 15.8 1, 153.3, 143.6, 143.1, 138.0, 137.6, 132.6, 130.4, 129.9 (x2), 128.4, 128.4, 128.1 (x2), 127.2 (x2), 125.3, 123.8, 121.4, 113.4, 56.2, 43.2, 36.7, 29.8, 21.7 153.3, 151.4, 149.2, 143.7, 143.5, 138.5, 137.6, 129.9 (x2), 128.3, 127.4 (x2), 125.2, 124.8, 123.5, 121.3, 121.1, 113.1, 111.4, 109.9, 56.1, 55.9, 55.8, 43.3, 37.6, 30.7, 21.7; HRMS (ESI) : Mass calcd for (C 28 H 28 N 2 O 4 S)H + [M+H] + : 489.1843; found: 489.1843.
3-
2-methyl-2'-methylene-1'-(methylsulfonyl)spiro[indole-3,4'-piperidine]
(4d): Prepared according to the general procedure using sulfonamide 3d (50 mg, 0.20 mmol), propargyl carbonate 1 (41 mg, 0.26 mmol), Pd 2 (dba) 3 ·CHCl 3 (5 mg, 5 µmol), Xantphos (6 mg, 11 µmol), and CH 2 Cl 2 (5 mL) at 40 °C for 2 h. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 4d (54 mg, 93%) as a yellow solid. 2, 154.0, 141.7, 139.3, 128.4, 124.8, 123.4, 120.5, 109.1, 56.0, 42.8, 39.3, 37.8, 30.3, 16. 2'-methylene-1'-(methylsulfonyl)spiro[indole-3,4' -piperidine] (4k): Prepared according to the general procedure using sulfonamide 3k (47 mg, 0.20 mmol), propargyl carbonate 1 (41 mg, 0.26 mmol), Pd 2 (dba) 3 ·CHCl 3 (5 mg, 5 µmol), Xantphos (6 mg, 11 µmol), DIPEA (39 mg, 0.3 mmol), and CH 2 Cl 2 (5 mL) at 40 °C for 40 min. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 4k (34 mg, 60%) as a yellow solid. 5, 154.7, 141.3, 140.2, 128.7, 126.4, 122.4, 121.7, 109.3, 56.3, 44.3, 39.6, 37.5, 30. 7, 154.1, 143.7, 142.3, 140.5, 129.6 (x2), 128.1, 127.4 (x3), 124.5, 124.2, 120.3, 115.1, 57.9, 48.9, 39.7, 33.8, 23.8, 21.5, 16. 4a-methyl-3-methylene-2-tosyl-2,3,4,4a-tetrahydro-1H-pyrido[3,4-b] indole (4h): Prepared according to the general procedure using sulfonamide 3h (63 mg, 0.20 mmol), propargyl carbonate 1 (41 mg, 0.26 mmol), Pd 2 (dba) 3 ·CHCl 3 (5 mg, 5 µmol), Xantphos (6 mg, 11 µmol), and CH 2 Cl 2 (5 mL) at 40 °C for 18 h. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 4h (42 mg, 60%) as a white solid. 8, 136.4, 129.0 (x2), 128.3, 127.0 (x3), 126.4, 121.4, 119.3, 118.7, 109.1, 107.9, 106.0, 44.5, 43.4 (x2), 21.2, 8.2; IR (film) 1645 IR (film) , 1467 IR (film) , 1347 IR (film) , 1164 IR (film) , 1090 167.3, 153.8, 140.8, 140.2, 136.8, 128.7, 128.7 (x2), 127.4 (x2), 127.4, 125.6, 122.3, 120.5, 96.1, 46.5, 37.8, 36.7, 29.7, 16 
General Procedure for the Sigmatropic Rearrangement of Spiroindolenines
To a solution of indolenine (0.20 mmol) in CH 2 Cl 2 (5 mL) was added trifluoroacetic acid (91 mg, 0.80 mmol). This was allowed to stir for 1 h at ambient temperature. The reaction mixture was diluted with CH 2 Cl 2 (10 mL), washed with sat. aq. NaHCO 3 (10 mL) and brine. The organic layer was concentrated in vacuo. The residue was purified by flash column chromatography to give the desired products. -3-tosyl-1,2,3,6-tetrahydroazepino[4,5-b ]indole (6b): Prepared according to the general procedure using sulfonamide 3l (63 mg, 0.20 mmol), propargyl carbonate 1 (41 mg, 0.26 mmol), Pd 2 (dba) 3 ·CHCl 3 (5 mg, 5 µmol), Xantphos (6 mg, 11 µmol), and CH 2 Cl 2 (5 mL) at 40 °C for 4 h. After the reaction was cooled to ambient temperature, TFA (80 µL, 1.0 mmol) was added and the reaction was stirred at 23 °C for 1 h. Purified by flash column chromatography (20% EtOAc/Hexanes) to afford 6b (34 mg, 49% over two steps) as a yellow solid.
4-methyl
